NanoCarry - About the company
NanoCarry is an unfunded company based in Ramat Gan (Israel), founded in 2019 by Revital Mandil Levin, Rachela Popovtzer and Oshra Betzer. It operates as a Nanoparticle-based drug delivery for precise drug targeting. NanoCarry has not raised any funding yet. The company has 152 active competitors, including 41 funded and 6 that have exited. Its top competitors include companies like NeuroVision, Brain.Space and NeuroXess.
Company Details
Nanoparticle-based drug delivery for precise drug targeting. The technology combines disease targets and compounds with drug delivery for safe targeting. The hybrid nanoparticles are based on the imaging technique that can be applied to the treatment of neurological conditions.
- Website
- nanocarry.com
- Email ID
- *****@nanocarry.com
- Phone Number
- +972 **********
Key Metrics
Founded Year
2019
Location
Ramat Gan, Israel
Stage
Unfunded
Ranked
72nd among 152 active competitors
Employee Count
12 as on Aug 31, 2026
Similar Companies
Sign up to download NanoCarry's company profile
NanoCarry's funding and investors
NanoCarry has not raised any funding rounds yet.
NanoCarry's founders and board of directors
Founder? Claim ProfileThe founders of NanoCarry are Revital Mandil Levin, Rachela Popovtzer and Oshra Betzer. Revital Mandil Levin is the CEO of NanoCarry.
Here are the details of NanoCarry's key team members:
- Revital Mandil Levin: Co-Founder & CEO of NanoCarry.
- Rachela Popovtzer: Co-Founder of NanoCarry.
- Oshra Betzer: Co-Founder of NanoCarry.
View details of NanoCarry's Founder profiles and Board Members
NanoCarry's employee count trend
NanoCarry has 12 employees as of Aug 26. Here is NanoCarry's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
NanoCarry's Competitors and alternates
Top competitors of NanoCarry include NeuroVision, Brain.Space and NeuroXess. Here is the list of Top 10 competitors of NanoCarry, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | NeuroVision 2010, Sacramento (United States), Series C | Provider of telehealth platform offering diagnostic and preventative neurology services | $20.4M | 56/100 | |
2nd | Brain.Space 2018, Tel Aviv (Israel), Series A | Digital brain activity analysis device for providers | $19.5M | 54/100 | |
3rd | Provider of decision-support diagnostic solutions for healthcare organizations | $13.9M | 52/100 | ||
4th | Augmental Tech 2018, Somerville (United States), Seed | Provider of an AR based solution to discreet hands-free mobile device interaction | $105K | 52/100 | |
5th | Openwater 2016, San Francisco (United States), Series C | Provider of imaging technologies for medical diagnosis and treatments | $100M | 49/100 | |
6th | BrainSpace 2021, Bothell (United States), Seed | Wearable ventricular drain monitoring solutions for physicians | $280K | 45/100 | |
7th | QuantalX NeuroScience 2014, Ness Ziona (Israel), Funding Raised | Provider of AI-based diagnostic software for brain diseases | - | 44/100 | |
8th | PanGenomic 2020, Vancouver (Canada), Public | Online teleconsultation platform for the patients and healthcare providers | - | 44/100 | |
9th | ANT Neuro 1997, Enschede (Netherlands), Unfunded | Digital neurodiagnostic solution for providers | - | - | 43/100 |
10th | Rhaeos 2018, Evanston (United States), Series A | Developer of a noninvasive device to monitor CSF and manage hydrocephalus | $12.8M | 42/100 | |
72nd | Nanoparticle-based drug delivery for precise drug targeting | - | - | 26/100 |
Looking for more details on NanoCarry's competitors? Click here to see the top ones
NanoCarry's Investments and acquisitions
NanoCarry has made no investments or acquisitions yet.
Reports related to NanoCarry
Here is the latest report on NanoCarry's sector:
News related to NanoCarry
•
Genuv Teams With Nanocarry Therapeutics to Develop Novel anti-PD-1 mAb Treatments That Can Cross the Blood-Brain BarrierBusiness Wire•Jun 06, 2022•GENUV, NanoCarry
Are you a Founder ?
FAQs about NanoCarry
Explore our recently published companies
- Approachable Systems - Columbia based, 2021 founded, Unfunded company
- Szybki SMS - Rzeszow based, Unfunded company
- LegalWills - Ottawa based, 2000 founded, Unfunded company
- Launch Education - Los Angeles based, 2022 founded, Unfunded company
- We are Family - Luxembourg based, 2020 founded, Unfunded company
- Rediscover Sports - United States based, 2026 founded, Unfunded company
